Skip to main content
. Author manuscript; available in PMC: 2013 Mar 13.
Published in final edited form as: Iran J Kidney Dis. 2012 Nov;6(6):432–436.

Table 1.

Characteristics of Patients Included in the Study*

Characteristic Number (%)
Female 68 (38)
Caucasian 166 (93)
Comorbidities
 Diabetes mellitus 108 (61)
 Hypertension 112 (62)
 Coronary artery disease 118 (66)
Contrast medium
 Iohexol 112 (63)
 Iodixinol 63 (35)
 Combination 4 (2)
RAAS blockade agent
 ACE inhibitor 62 (35)
 ARB 11 (7)
 Combination 1 (1)
Prophylactic strategies
 Bicarbonate 5 (3)
 Normal saline 144 (81)
 N-acteylcysteine 51 (29)
*

RAAS indicates rennin-angiotensin-aldosterone system; ACE, angiotensin-converting enzyme; and ARB, angiotensin receptor blocker.